Acetorphine.

Acetyl-alpha-methylfentanyl.

Alkoxyamfetamines and substituted alkoxyamfetamines except when separately specified in the schedules to these Regulations.

Alkoxyphenylethylamines and substituted alkoxyphenylethylamines except when separately specified in the schedules to these Regulations.

Alkylthioamfetamines and substituted alkylthioamfetamines except when separately specified in the schedules to these Regulations.

Allylprodine.

Alphameprodine.

Alpha-methylfentanyl.

Alpha-methylthiofentanyl.

Alphamethadol.

Alpha-pyrrolidinovalerophenone *(alpha-pvp).

2-amino-1-(2,5-dimethoxy-4-methyl)phenylpropane *(stp or dom).

5-(2-aminopropyl)indan and substituted 5-(2-aminopropyl)indans except when separately specified in the schedules to these Regulations.

Benzethidine.

Benzoylindoles except when separately specified in the schedules to these Regulations.

Benzylpiperazine *(bzp).

Betacetylmethadol.

Beta-hydroxyfentanyl.

Beta-hydroxy-3-methylfentanyl.

Betameprodine.

Betamethadol.

Betaprodine.

1-(8-bromobenzo[1,2-b;4,5-b]difuran-4-yl)-2-aminopropane *(bromo-dragonfly).

4-bromo-2,5-dimethoxyphenethylamine *(bdmpea).

Bufotenine.

Cannabis (including seeds, extracts, resins, tinctures and the plant and any part of the plant whether fresh, dried or otherwise).

Carfentanyl.

Cathinones except when separately specified in the schedules to these Regulations.

Clonazolam.

Clonitazene.

Coca leaf.

Codoxime.

4-cyano-2-dimethylamino-4,4’-diphenylbutane.

Cyclohexylphenols except—

• (a)when separately specified in the schedules to these Regulations; or
• (b)in preparations containing 0.5 per cent or less of cyclohexylphenols.

Deschloroetizolam.

Desomorphine.

N,n-dialkylaminocyclohexyl alkyl benzamides except when separately specified in the schedules to these Regulations.

N,n-dialkylaminocyclohexylmethyl alkyl benzamides except when separately specified in the schedules to these Regulations.

Diampromide.

Dibenzopyrans except when separately specified in the schedules to these Regulations.

3,4-dichloro-n-[(1r,2r)-2-(dimethylamino)cyclohexyl]-n-methylbenzamide (u-47700).

3,4-dichloro-n-{[1- (dimethylamino)cyclohexyl]methyl}benzamide *(ah-7921).

Diclazepam.

Diethylthiambutene.

N,n-diethyltryptamine *(det).

Dimenoxadol.

Dimepheptanol.

2,5-dimethoxyamfetamine *(dma).

2,5-dimethoxy-4-bromoamfetamine *(dob).

2,5-dimethoxy-4-ethyl-a-amfetamine *(doet).

2,5-dimethoxy-4-ethylthiophenethylamine *(2c-t-2).

2,5-dimethoxy-4-iodophenethylamine *(2c-i).

2,5-dimethoxy-4-(n)-propylthiophenethylamine *(2c-t-7).

3-(2-dimethylaminoethyl)-4-hydroxyindole *(psilocine or psilotsin).

3-(1,2-dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6h-dibenzo (b,d) pyran *(dmhp).

N, α-dimethyl-3,4-(methylenedioxy)phenylethylamine *(mdma).

N,n-dimethylamfetamine (dimetamfetamine).

Dimethylthiambutene.

N,n-dimethyltryptamine *(dmt).

Dioxaphetyl butyrate.

Ecgonine.

N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine *(n-ethyl mda).

Ethylmethylthiambutene.

Eticyclidine *(pce).

Etonitazene.

Etorphine.

Etoxeridine.

Fenetylline.

4-fluoro-n-methylamfetamine.

Flubromazepam.

Flubromazolam.

1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole *(am-694).

Furethidine.

Harmala alkaloids except in herbs, or preparations, for therapeutic use—

• (a)containing 0.1 per cent or less of harmala alkaloids; or
• (b)in divided preparations containing 2 mg or less of harmala alkaloids per recommended daily dose.

Heroin.

3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6h-dibenzo (b,d) pyran *(parahexyl).

4-hydroxybutanoic acid and its salts except for sodium oxybate when in Schedule 8. *(gamma hydroxybutyrate (ghb)).

2-[(1r,3s)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol *(cannabicyclohexanol or cp 47,497 c8 homologue).

2-[(1r,3s)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol *(cp 47,497).

Hydroxypethidine.

Isomethadone.

Ketobemidone.

Levomethorphan (excluding its stereoisomers).

Levophenacylmorphan.

Lysergic acid.

Lysergide.

Meclonazepam.

Mecloqualone.

Metazocine.

Methaqualone.

Methcathinone.

5-methoxy- α –methyltryptamine *(5-meo-amt).

5-methoxy-3,4-methylenedioxyamfetamine *(mmda).

4-methoxy- α –methylphenylethylamine *(pma).

2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone *(jwh-250).

Methyl (2s, 4ar, 6ar, 7r, 9s, 10as, 10br)-9-acetoxy-6a,10b-dimethyl-4,10-dioxo-dodecahydro-2-(3-furyl)-2h-naphtho[2,1-c]pyran-7-carboxylate *(salvinorin a).

4-methylaminorex.

Methyldesorphine.

3,4-methylenedioxyamfetamine *(mda).

3,4-methylenedioxypyrovalerone *(mdpv).

3-methylfentanyl.

4-methylmethcathinone *(mephedrone).

N- α-[methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine *(n-hydroxy mda).

N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine *(mbdb).

2-methyl-3-morpholino-1, 1-diphenylpropane carboxylic acid (moramide intermediate).

Methylone *(mdmc).

1-methyl-4-phenyl-4-piperidinol propionate *(mppp).

4-methylthioamfetamine.

3-methylthiofentanyl.

Metopon.

Mitragyna speciosa.

Mitragynine.

Morpheridine.

(1-(2-morpholin-4-ylethyl)indol-3-yl)-napthalen-1-ylmethanone *(jwh-200).

Muscimol.

Myrophine.

Naphthoylindoles except when separately specified in the schedules to these Regulations.

Naphthylmethylindoles except when separately specified in the schedules to these Regulations.

Naphthoylpyrroles except when separately specified in the schedules to these Regulations.

Naphthylmethylindenes except when separately specified in the schedules to these Regulations.

Naphthalen-1-yl-(1-butylindol-3-yl)methanone *(jwh-073).

Nicocodine.

Nicodicodine.

Nicomorphine.

Nifoxipam.

Noracymethadol.

Norlevorphanol.

Normorphine.

Norpipanone.

Opium.

Para-fluorofentanyl.

1-pentyl-3-(4-methyl-1-napthoyl)indole. *(jwh-122).

1-pentyl-3-(1-naphthoyl)indole *(jwh-018).

Phenadoxone.

Phenampromide.

Phenazocine.

Phencyclidine *(pcp).

Phenibut.

N-phenethyl-4-piperidone.

Phenomorphan.

Phenylacetylindoles except when separately specified in the schedules to these Regulations.

1-phenylethyl-4-phenyl-4-piperidinol acetate *(pepap).

Piminodine.

Proheptazine.

Properidine.

Psilocybine.

Pyrazolam.

Racemethorphan.

Racemorphan.

Rolicyclidine *(php or pcpy).

Salvia divinorum.

Synthetic cannabinomimetics except when separately specified in the schedules to these Regulations.

Tenocyclidine *(tcp).

Tetrahydrocannabinols and their alkyl homologues, except—

• (a)when included in schedules 4 or 8;
• (b)processed hemp fibre containing 0.1 per cent or less of tetrahydrocannabinols, and hemp fibre products manufactured from such fibre; or
• (c)in hemp seed oil for purposes other than internal human use containing 50 mg/kg or less of total cannabinoids, including 20 mg/kg or less of tetrahydrocannabinols, when labelled with either of the following warning statements “Not for internal use” or “Not to be taken”.

Thiofentanyl.

1-(3-trifluoromethylphenyl)piperazine *(tfmpp).

Trimeperidine.

3,4,5-trimethoxy- α –methylphenylethylamine *(tma).

3,4,5-trimethoxyphenethylamine (mescaline) and other substances structurally derived from methoxy-phenylethylamine except—

• (a)methoxyphenamine; or
• (b)when separately specified in this Schedule.

1-(3,4,5-trimethoxyphenyl)-2-aminobutane.